Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Radiotherapy with CAR-T Cells in Hematological Malignancies
NCT04790747Phase 2Unknown
- Sponsor
- Zhejiang University
- Start
- Mar 2021
- Primary completion
- Mar 2024
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of LV20.19 CAR-T in B-cell non-Hodgkin lymphoma, multiple myeloma (MM), acute lymphoblastic leukemia (ALL), sponsored by Zhejiang University. Status: unknown.
02
Drugs
LV20.19 CAR-T
03
Conditions
B-cell non-Hodgkin lymphomamultiple myeloma (MM)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT04790747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04790747.